Insider Shareholders with Direct Ownership of Vigil Neuroscience, Inc. (VIGL)
This section provides a comprehensive overview of the insiders with direct ownership of Vigil Neuroscience, Inc. (VIGL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Vigil Neuroscience, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Amgen Inc
> 10% Shareholder |
3,206,281 | 0 | 3,206,281 $5.23 Million | 1 |
Jan 11, 2022
Added 50.0%
|
Ivana Magovcevic Liebisch
President and CEO |
24,000 | 0 | 222,687 $362,979 | 6 |
Dec 19, 2024
Added 2.2%
|
Alexandria Venture Investments, Llc
> 10% Shareholder |
192,973 | 0 | 192,973 $314,545 | 1 |
Jan 11, 2022
Added 50.0%
|
12,000 | 0 | 12,000 $19,560 | 1 |
Dec 19, 2024
Added 50.0%
|
|
Jennifer Lynn Ziolkowski
Chief Financial Officer |
4,000 | 0 | 4,000 $6,520 | 1 |
May 03, 2022
Added 50.0%
|
Spyridon Papapetropoulos
Chief Medical Officer |
4,300 | 300 | 4,000 $6,520 | 3 |
Nov 18, 2022
Reduced 6.98%
|
Christopher Verni
General Counsel |
4,000 | 0 | 4,000 $6,520 | 1 |
May 03, 2022
Added 50.0%
|
Clay Thorp
Director |
3,000 | 0 | 3,000 $4,890 | 1 |
Mar 28, 2022
Added 50.0%
|
Evan Thackaberry
SVP, Head of Early Development |
1,500 | 0 | 1,500 $2,445 | 1 |
May 05, 2022
Added 50.0%
|